Omega-3 Supplements Linked to Fewer Pain Crises in Children With Sickle Cell Disease
This clinical trial followed 165 children with sickle cell disease over 10 months. All patients continued their usual standard therapy (hydroxyurea plus ibuprofen), but were also randomly assigned to receive either a daily omega-3 fish oil supplement (providing EPA and DHA), a vitamin D supplement, or standard therapy alone.
Researchers tracked how often painful crises occurred and how severe the pain was using a standard pain-rating scale, along with blood markers like cholesterol levels, red blood cell counts, and white blood cell counts.
By the end of the study, children taking omega-3 experienced fewer pain episodes and lower pain scores compared with those on standard therapy alone. The omega-3 group also showed higher HDL and LDL cholesterol levels than the control group. Vitamin D supplementation showed some benefit over standard therapy alone, but less than omega-3.
What this means for you
For families managing pediatric sickle cell disease, this study suggests that adding an omega-3 supplement to standard medical treatment may be associated with fewer and less severe pain crises, though this is one trial and any supplement decisions for a serious condition like sickle cell disease should be made together with a treating physician.
Ready to start? The ALP Protocol delivers the EPA & DHA doses used in the research.
Start the ALP ProtocolSource
European review for medical and pharmacological sciences · 2022-07-01 · DOI: 10.26355/eurrev_202207_29290
Read the original source ↗This summary is for educational purposes only and is not medical advice. Always talk to your healthcare provider before making changes to your supplement routine.